All Insights

Intellectual property

Court of Appeal finds inventors must be human

An artificial intelligence (AI) machine cannot be an 'inventor' for purpose of Patents Act 1977 and owner of machinery cannot

Intellectual property

Skykick: Court of Appeal endorses broad terms and clarifies the scope of bad faith

Ruling confirms that brand owners can continue to rely on broad terms and a lack of intention to use is

Intellectual property

Wind power boom is fanning high-stakes international patent activity

The ancient form of power generation is now the world's number two source of renewable electricity, and its high profile

Future of work

Future of Work podcast | The hybrid working series: mitigating IP & commercial risks

In this episode of our Future of Work hybrid working series, Employment Partner Olivia Sinfield talks with Becky Crawford, a

Intellectual property

Greenwashing in advertising: legal requirements in Germany for claims on environmental protection and sustainability

There are numerous legal pitfalls when companies incorporate sustainability and environmental protection into their advertising claims. What needs to be

Digitalisation

The PRC Personal Information Protection Law, China’s GDPR – in a nutshell

New law sets out comprehensive sets of rules on the collection, processing and protection of personal information for the first

Technology, Media and Telecommunications (TMT)

New levy obligations for audiovisual media services adopted in France

The French government has moved ahead with its far-reaching reforms of the financing of audio-visual and cinema productions

Intellectual property

Court of Appeal judge provides obiter guidance on the correct application of Formstein defence in the UK

The decision provides a further example that the UK courts are likely to accept the Formstein defence, when required, and

Intellectual property

Car wars: how tech ownership battles will decide the future leaders of autonomous vehicles

An upsurge in patent filings by new competitors in the autonomous vehicles arena means incumbents need to strengthen their IP

Life Sciences and Healthcare

Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries

Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?